Novartis

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Novartis and other ETFs, options, and stocks.

About NVS

Novartis AG is a holding company, which engages in the business of developing, manufacturing, and marketing healthcare products. Its product portfolio is heavily focused on innovative prescription medicines, especially oncology, immunology, neuroscience, and cardiovascular diseases, supplemented by established older brands and a wide range of specialized therapies.

CEO

Vasant Narasimhan

CEOVasant Narasimhan

Employees

75,267

Employees75,267

Headquarters

Basel, Basel-Stadt (Basle Town)

HeadquartersBasel, Basel-Stadt (Basle Town)

Founded

1996

Founded1996

Employees

75,267

Employees75,267

NVS Key Statistics

Market cap

326.23B

Market cap326.23B

Price-Earnings ratio

30.46

Price-Earnings ratio30.46

Dividend yield

1.92%

Dividend yield1.92%

Average volume

2.11M

Average volume2.11M

High today

$161.76

High today$161.76

Low today

$160.03

Low today$160.03

Open price

$160.98

Open price$160.98

Volume

935.68K

Volume935.68K

52 Week high

$170.46

52 Week high$170.46

52 Week low

$123.24

52 Week low$123.24

NVS News

Seeking Alpha 2d

Novartis releases long-term data for ianalumab in Sjögren’s disease

Novartis releases long-term data for ianalumab in Sjögren’s disease Nov 10, 2026, 2:07 PM ET Novartis AG (NVS) Stock By : Jonathan Block, SA News Editor Novarti...

Zacks 2d

Zacks Industry Outlook Highlights Eli Lilly, Novartis and Bayer

Chicago, IL – November 10, 2026 – Today, Zacks Equity Research discusses Eli Lilly (LLY Quick QuoteLLY - Free Report) , Novartis (NVS Quick QuoteNVS - Fr...

Seeking Alpha 5d

Novartis is said to be abandoning Ionis heart drug after late-stage trial setback

Novartis (NVS) is largely abandoning the development of a heart disease therapy discovered by Ionis Pharmaceuticals (IONS) after the RNA-targeting therapy faile...

Analyst ratings

56%

of 9 ratings

Buy

55.6%

Hold

44.4%

Sell

More NVS News

Seeking Alpha 7d

Novartis slips amid safety concerns tied to Zolgensma

Novartis (NVS) ADRs fell on Thursday after patient advocates highlighted safety concerns potentially linked to its gene therapy, Zolgensma, including nine cases...

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.